Forms A and B of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl ]thio]ethyl]amino]methylene]-4-bromo-benzenesulfonamide

PCT No. PCT/ES94/00109 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Nov. 4, 1994 PCT Pub. No. WO96/14306 PCT Pub. Date May 17, 1996Two forms of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-benzenesulfonamidehave been identified. A...

Full description

Saved in:
Bibliographic Details
Main Authors FOGUET; RAFAEL, ORTIZ; JOSEA, SACRISTAN; AURELIO, ANGLADA; LLUIS, CASTELLO; JOSEP M
Format Patent
LanguageEnglish
Published 21.12.1999
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/ES94/00109 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Nov. 4, 1994 PCT Pub. No. WO96/14306 PCT Pub. Date May 17, 1996Two forms of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-benzenesulfonamidehave been identified. A process for the preparation of thereof and the use thereof are described.
Bibliography:Application Number: US19960669359